Evidence map›Paper›PMID 37651654›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.

Thomas Cash, Mark D Krailo, Allen B Buxton, Bruce R Pawel, John H Healey, Odion Binitie, Karen J Marcus, Holcombe E Grier, Patrick J Grohar, Damon R Reed and 5 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Sarcomas in Adolescents and Young Adults.Current oncology reports · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Thomas CashDepartment of Pediatrics, Emory University, Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta, Atlanta, GA.ORCID 0000-0002-1128-784X
Mark D KrailoChildren's Oncology Group, Monrovia, CA.
Allen B BuxtonChildren's Oncology Group, Monrovia, CA.
Bruce R PawelDepartment of Pathology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA.ORCID 0000-0001-7678-5324
John H HealeyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-0802-1186
Odion BinitieDepartment of Sarcoma, Moffitt Cancer Center, Tampa, FL.
Karen J MarcusDepartment of Radiation Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.ORCID 0000-0001-5156-6336
Holcombe E GrierDepartment of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.ORCID 0009-0001-7701-2304
Patrick J GroharDepartment of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0002-1071-4563
Damon R ReedDepartment of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.ORCID 0000-0002-8238-2465
Aaron R WeissDepartment of Pediatrics, Maine Medical Center, Portland, ME.ORCID 0000-0001-8352-3963
Richard GorlickDivision of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-8995-2929
Katherine A JanewayDepartment of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.ORCID 0000-0001-6000-3594
Steven G DuBoisDepartment of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.ORCID 0000-0003-0882-738X
Richard B WomerDepartment of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA.ORCID 0000-0002-4405-1200
Dana-Farber/Boston Children's Cancer and Blood Disorders Center · USChildren's Hospital of Philadelphia · USMoffitt Cancer Center · USUniversity of Southern California · USChildren's Oncology Group · USEmory University · USMaine Medical Center · USMemorial Sloan Kettering Cancer Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the LifespanUG1CA239771 · NCI · MAINEHEALTH · PI Leslie Bradford, Christine Lu-Emerson · 2019 to 2026
$7.9M
NCI NIH HHS P30 CA008748NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCI NIH HHS UG1 CA239771
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone NeoplasmsSarcoma, EwingAntineoplastic Combined Chemotherapy ProtocolsChildDoxorubicinEtoposideHumansIfosfamideVincristineDoxorubicinEtoposideIfosfamideVincristine

Identifiers

PMID37651654
PMCPMC10602538
OpenAlexW4386316250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.